Whole body MRI: Improved lesion detection and characterization with diffusion weighted techniques

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 2, 2013, Pages 253-268

  Attariwala, Rajpaul ^a   Picker, Wayne ^a  

^a AIM Medical Imaging   (Canada)

Author keywords

apparent diffusion coefficient ADC; b value; diffusion weighted imaging DWI; MRI; whole body MRI; oncology imaging

Indexed keywords

ANGIOGENESIS INHIBITOR; FLUORODEOXYGLUCOSE; GADOLINIUM; WATER;

ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADENOCARCINOMA; ARTIFACT; ASCITES; BLADDER CARCINOMA; BLADDER METASTASIS; BLADDER TUMOR; BONE METASTASIS; BONE SCINTISCANNING; BREAST CARCINOMA; BREAST LESION; BREAST TUMOR; BREATHING MECHANICS; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CARCINOMATOUS PERITONITIS; CHEMOEMBOLIZATION; CHRONIC KIDNEY FAILURE; COLONOSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; CREATININE CLEARANCE; CROHN DISEASE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EMPYEMA; ENDOMETRIOSIS; ENDOMETRIUM CANCER; FIBRONODULAR HYPERPLASIA; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HEMANGIOMA; HEMATURIA; HUMAN; KIDNEY ARTERY STENOSIS; KIDNEY GRAFT; KIDNEY PERFUSION; KIDNEY TUMOR; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER HYPERPLASIA; LUNG NODULE; LUNG SMALL CELL CANCER; LYMPHOMA; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OVARY CARCINOMA; PANCREAS ADENOCARCINOMA; PANCREAS ISLET CELL TUMOR; PANCREATITIS; PLEURA EFFUSION; PRIORITY JOURNAL; PYELONEPHRITIS; QUANTITATIVE ANALYSIS; RECTUM CARCINOMA; RESPIRATORY GATED IMAGING; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION; ULCERATIVE COLITIS; UTERINE CERVIX CARCINOMA; WHOLE BODY MRI;

APPARENT DIFFUSION COEFFICIENT ADC; B-VALUE; DIFFUSION-WEIGHTED IMAGING DWI; MRI; WHOLE BODY MRI; ONCOLOGY IMAGING;

ALGORITHMS; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; NEOPLASMS; PATTERN RECOGNITION, AUTOMATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

EID: 84882620253     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24285     Document Type: Review

References (145)

1. Eustace S, Tello R, DeCarvalho V, Carey J, Melhem E, Yucel EK,. Whole body turbo STIR MRI in unknown primary tumor detection. J Magn Reson Imaging 1998; 8: 751-753. (Pubitemid 28267802)
2. Steinborn MM, Heuck AF, Tiling R, Bruegel M, Gauger L, Reiser MF,. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 1999; 23: 123-129. (Pubitemid 29095482)
3. Lauenstein TC, Freudenberg LS, Goehde SC, et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 2002; 12: 2091-2099. (Pubitemid 36940299)
4. Kruger DG, Riederer SJ, Grimm RC, Rossman PJ,. Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med 2002; 47: 224-231. (Pubitemid 34116789)
5. Engelhard K, Hollenbach HP, Wohlfart K, von Imhoff E, Fellner FA,. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 2004; 14: 99-105. (Pubitemid 38181060)
6. LeBihan D, Breton E,. Imagerie de diffusion in-vivo par resonance. C R Acad Sci (Paris) 1985; 301: 1109-1112.
7. Muller MF, Edelman RR,. Echo planar imaging of the abdomen. Top Magn Reson Imaging 1995; 7: 112-119.
8. Wang Y,. Description of parallel imaging in MRI using multiple coils. Magn Reson Med 2000; 44: 495-499.
9. Schmidt GP, Schoenberg SO, Schmid R, et al. Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 2007; 17: 939-949. (Pubitemid 46766875)
10. Stejskal EO, Tanner JE,. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965; 42: 288-293.
11. Einstein A,. On the movement of small particles suspended in stationary liquids required by the kinetic theory of heat. Ann Der Physik 1905; 17: 549-560.
12. Takahara T, Imai Y, Yamashita T, et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22: 275-282. (Pubitemid 39264807)
13. Koh D-M, Blackledge M, Padhani AR, et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls. AJR Am J Roentgenol 2012; 199: 252-262.
14. LeBihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M,. MR Imaging of incoherent motion: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161: 401-407. (Pubitemid 17173295)
15. Koh DM, Collins DJ, Orton MR,. Intravoxel incoherent motion in body diffusion-weighted MRI: reality and challenges. AJR Am J Roentgenol 2011; 196: 1351-1361.
16. LeBihan D, Turner R,. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 1992; 27: 171-178.
17. Lemke A, Laun FB, Simon D, Stieltjes B, Schad LR,. An in vivo verification of the intravoxel incoherent motion effect in diffusion-weighted imaging of the abdomen. Magn Reson Med 2010; 64: 1580-1585.
18. Uto T, Takehara Y, Nakamura Y, et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009; 252: 247-254.
19. Baysal T, Bulut T, Gokirmak M, et al. Diffusion-weighted MR imaging of pleural fluid: differentiation of transudative vs exudative pleural effusions. Eur Radiol 2004; 14: 890-896. (Pubitemid 38678912)
20. Inan N, Arslan A, Akansel G, et al. Diffusion-weighted MRI in the characterization of pleural effusions. Diag Interv Radiol 2009; 15: 13-18.
21. Bozkurt M, Doganay S, Kantarci M, et al. Comparison of peritoneal tumor imaging using conventional MR imaging and diffusion-weighted MR imaging with different b values. Eur J Radiol 2011; 80: 224-228.
22. Low RN, Sebrechts CP, Barone RM, Muller W,. Diffusion-weighted MRI of peritoneal tumors: comparison with conventional MRI and surgical and histopathologic findings-a feasibility study. AJR Am J Roentgenol 2009; 193: 461-470.
23. Padhani AR, Liu G, Koh DM, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-125.
24. Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B,. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. J Magn Reson Imaging 2011; 33: 128-135.
25. Ziegelberger G, Ingolstaedter L,. ICNIRP Statement on the "guidelines for limiting exposure to time-varying electric, magnetic and electromagnetic fields (up to 300GHz)". Health Phys 2009; 97: 257-258.
26. International Commission on Non-Ionizing Radiation Protection. Guidelines on limiting exposure to static magnetic fields. Health Phys 2009; 96: 504-514.
27. Harvey PR, Zhai Z, Morich M, et al. SAR behavior during whole-body multitransmit RF shimming at 3.0T. In: Proceedings of the 17th Annual Meeting of ISMRM, Honolulu, 2009. (abstract 4786).
28. Neufeld E, Gosselin M-C, Murbach M, et al. Analysis of the local worst-case SAR exposure caused by an MRI multi-transmit body coil in anatomical models of the human body. Phys Med Biol 2011; 56: 4649-4659.
29. Enroth-Cugell C, Shapley RM,. Flux, not retinal illumination, is what cat retinal ganglion cells really care about. J Physiol 1973; 233: 311-326.
30. Padhani AR, Koh DM, Collins DJ,. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 2011; 261: 700-718.
31. Atlas SW, DuBois P, Singer MB, Lu D,. Diffusion measurements in intracranial hematomas: implications for MR imaging of acute stroke. AJNR Am J Neuroradiol 2000; 21: 1190-1194. (Pubitemid 30655651)
32. Goodsitt MM, Hoover P, Veldee MS, Hsueh SL,. The composition of bone marrow for a dual-energy quantitative computed tomography technique. A cadaver and computer simulation study. Invest Radiol 1994; 29: 695-704. (Pubitemid 24258265)
33. Stecco A, Lombardi M, Leva L, et al. Diagnostic accuracy and agreement between whole-body diffusion MRI and bone scintigraphy in detecting bone metastases. Radiol Med 2013; 118: 465-475.
34. Mosavi F, Johansson S, Sandberg DT, Turesson I, Sorensen J, Ahlstrom H,. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma. AJR Am J Roentgenol 2012; 199: 1114-1120.
35. Liu X, Zhou L, Peng W, Qian M,. Effect of intravenous gadolinium-DTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging. Acta Radiol 2011; 52: 575-580.
36. Wang CL, Chea YW, Boll DT, et al. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. Eur J Radiol 2011; 80: e1-e7.
37. Kinner S, Umutlu L, Blex S, et al. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable? Eur J Radiol 2012; 81: e625-e628.
38. Kwee TC, van Ufford HM, Beek FJ, et al. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 2009; 44: 683-690.
39. Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL,. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 2011; 197: W384-W391.
40. Fischer MA, Nanz D, Hany T, et al. Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT. Eur Radiol 2011; 21: 246-255.
41. Manenti G, Ciccio C, Squillaci E, et al. Role of combined DWIBS/3D-CE-T1w whole-body MRI in tumor staging: comparison with PET-CT. Eur J Radiol 2012; 81: 1917-1925.
42. Xu GZ, Li CY, Zhao L, He ZY,. Comparison of FDG whole-body PET/CT and gadolinium-enhanced whole-body MRI for distant malignancies in patients with malignant tumors: a meta-analysis. Ann Oncol 2013; 24: 96-101.
43. Sommer G, Klarhofer M, Lenz C, et al. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression. Eur Radiol 2011; 21: 857-862.
44. Schmidt GP, Reiser MF, Baur-Melnyk A,. Whole-body MRI for the staging and follow-up of patients with metastasis. Eur J Radiol 2009; 70: 393-400.
45. Marzolini M, Wong WL, Ardeshna K, Padhani A, D'Sa S,. Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma. Br J Hematol 2012; 156: 557.
46. Padhani AR, Gogbashian A,. Bony metastases: assessing response to therapy with whole-body diffusion MRI. Cancer imaging 2011;(1 1 Spec No): S129-S145.
47. Thoeny HC, De Keyzer F, King AD,. Diffusion-weighted MR imaging in the head and neck. Radiology 2012; 263: 19-32.
48. Mutlu H, Sivrioglu AK, Sonmez G, et al. Role of apparent diffusion coefficient values and diffusion-weighted magnetic resonance imaging in differentiation between benign and malignant thyroid nodules. Clin Imaging 2012; 36: 1-7.
49. Nakahira M, Saito N, Murata S-I, et al. Quantitative diffusion-weighted magnetic resonance imaging as a powerful adjunct to fine needle aspiration cytology for assessment of thyroid nodules. Am J Otolaryngol 2012; 33: 408-416.
50. Lambrecht M, Dirix P, Vandecaveye V, et al. Role and value of diffusion-weighted MRI in the radiotherapeutic management of head and neck cancer. Exp Rev Anticancer Ther 2010; 10: 1451-1459.
51. Wu L-M, Xu J-R, Liu M-J, et al. Value of magnetic resonance imaging for nodal staging in patients with head and neck squamous cell carcinoma: a meta-analysis. Acad Radiol 2012; 19: 674.
52. Yun TJ, Kim J-H, Kim KH, Sohn C-H, Park S-W,. Head and neck squamous cell carcinoma: differentiation of histologic grade with standard- and high-b-value diffusion-weighted MRI. Head Neck 2013; 35: 626-631.
53. Nakamatsu S, Matsusue E, Miyoshi H, et al. Correlation of apparent diffusion coefficients measured by diffusion-weighted MR imaging and standardized uptake values from FDG PET/CT in metastatic neck lymph nodes of head and neck squamous cell carcinomas. Clin Imaging 2012; 36: 90-97.
54. Nakajo M, Nakajo M, Kajiya Y, et al. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient. Clin Nucl Med 2012; 37: 475-480.
55. Quon H, Brizel DM,. Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas. Semin Radiat Oncol 2012; 22: 220-232.
56. Berrak S, Chawla S, Kim S, et al. Diffusion-weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy. Acad Radiol 2011; 18: 1225-1232.
57. T, Mutlu, DY, Yologlu, S,. Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma. Magn Reson Imaging 2009; 27: 1447-1454.
58. Regier M, Schwarz D, Henes FO, et al. Diffusion-weighted MR-imaging for the detection of pulmonary nodules at 1.5 Tesla: intraindividual comparison with multidetector computed tomography. J Med Imaging Radiat Oncol 2011; 55: 266-274.
59. Ohba Y, Nomori H, Mori T, et al. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer? J Thoracic Cardiovasc Surg 2009; 138: 439-445.
60. Regier M, Derlin T, Schwarz D, et al. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)? Eur J Radiol 2012; 81: 2913-2918.
61. Wu L-M, Xu J-R, Gu H-Y, et al. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? J Surg Res 2012; 178: 304-314.
62. Pauls S, Schmidt SA, Juchems MS, et al. Diffusion-weighted MR imaging in comparison to integrated [18F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol 2012; 81: 178-182.
63. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008; 248: 643-654.
64. Partridge SC, McKinnon GC, Henry RG, Hylton NM,. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI. J Magn Reson Imaging 2001; 14: 433-438. (Pubitemid 32906561)
65. Partridge SC, Demartini WB, Kurland BF, Eby PR, White SW, Lehman CD,. Differential diagnosis of mammographically and clinically occult breast lesions on diffusion-weighted MRI. J Magn Reson Imaging 2010; 31: 562-570.
66. Partridge SC, Rahbar H, Murthy R, et al. Improved diagnostic accuracy of breast MRI through combined apparent diffusion coefficients and dynamic contrast-enhanced kinetics. Magn Reson Med 2011; 1767: 1759-1767.
67. Partridge SC, DeMartini WB, Kurland BF, Eby PR, White SW, Lehman CD,. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 2009; 193: 1716-1722.
68. Sigmund EE, Cho GY, Kim S, et al. Intravoxel incoherent motion imaging of tumor microenvironment in locally advanced breast cancer. Magn Reson Med 2011; 65: 1437-1447.
69. Kazama T, Kuroki Y, Kikuchi M, et al. Diffusion-weighted MRI as an adjunct to mammography in women under 50 years of age: an initial study. J Magn Reson Imaging 2012; 36: 139-144.
70. Jones RA, Grattan-Smith JD,. Age dependence of the renal apparent diffusion coefficient in children. Pediatr Radiol 2003; 33: 850-854. (Pubitemid 38008333)
71. Verswijvel G, Vandecaveye V, Gelin G, et al. Diffusion-weighted MR imaging in the evaluation of renal infection: preliminary results. JBR-BTR. 2002; 85: 100-103. (Pubitemid 34587151)
72. Macarini L, Stoppino LP, Milillo P, Ciuffreda P, Fortunato F, Vinci R,. Diffusion-weighted MRI with parallel imaging technique: apparent diffusion coefficient determination in normal kidneys and in nonmalignant renal diseases. Clin Imaging 2010; 34: 432-440.
73. Cova M, Squillaci E, Stacul F, et al. Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results. Br J Radiol 2004; 77: 851-857. (Pubitemid 39504641)
74. Thoeny HC, De Keyzer F, Oyen RH, Peeters RR,. Diffusion-weighted MR imaging of kidneys in healthy volunteers and patients with parenchymal diseases: initial experience. Radiology 2005; 235: 911-917. (Pubitemid 40695889)
75. Thoeny HC, De Keyzer F,. Diffusion-weighted MR imaging of native and transplanted kidneys. Radiology 2011; 259: 25-38.
76. Eisenberger U, Thoeny HC, Binser T, et al. Evaluation of renal allograft function early after transplantation with diffusion-weighted MR imaging. Eur Radiol 2010; 20: 1374-1383.
77. Cova M, Squillaci E, Stacul F, et al. Diffusion-weighted MRI in the evaluation of renal lesions: preliminary results. Br J Radiol 2004; 77: 851-857. (Pubitemid 39504641)
78. Zhang J, Tehrani YM, Wang L, Ishill NM, Schwartz LH, Hricak H,. Renal masses: characterization with diffusion-weighted MR imaging-a preliminary experience. Radiology 2008; 247: 458-464.
79. Sandrasegaran K, Sundaram CP, Ramaswamy R, et al. Usefulness of diffusion-weighted imaging in the evaluation of renal masses. AJR Am J Roentgenol 2010 Feb; 194: 438-45.
80. Kim S, Jain M, Harris AB, et al. T1 hyperintense renal lesions: characterization with diffusion-weighted MR imaging versus contrast-enhanced MR imaging. Radiology 2009; 251: 796-807.
81. Wang H, Cheng L, Zhang X, et al. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology 2010; 257: 135-143.
82. Goyal A, Sharma R, Bhalla AS, et al. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype. Acta Radiol 2012; 53: 349-358.
83. Zhang JL, Sigmund EE, Chandarana H, et al. Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology 2010; 254: 783-792.
84. Zhang JL, Sigmund EE, Rusinek H, et al. Optimization of b-value sampling for diffusion-weighted imaging of the kidney. Magn Reson Med 2012; 67: 89-97.
85. Chandarana H, Lee VS, Hecht E, Taouli B, Sigmund EE,. Comparison of biexponential and monoexponential model of diffusion-weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol 2011; 46: 285-291.
86. Abou-El-Ghar ME, El-Assmy A, Refaie HF, El-Diasty T,. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 2009; 251: 415-421.
87. El-Assmy A, Abou-El-Ghar ME, Mosbah A, et al. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging. Eur Radiol 2009; 19: 1575-1581.
88. Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009; 251: 112-121.
89. Avcu S, Koseoglu MN, Ceylan K, Bulut MD, Dbulutand M, Unal O,. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol 2011; 84: 875-882.
90. Kobayashi S, Koga F, Yoshida S, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011; 21: 2178-2186.
91. Takeuchi M, Suzuki T, Sasaki S, et al. Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer. Acad Radiol 2012; 19: 827-833.
92. El-Assmy A, Abou-El-Ghar ME, Refaie HF, Mosbah A, El-Diasty T,. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience. BJU Int 2012; 110: e622-e627.
93. Tan CH, Wei W, Johnson V, Kundra V,. Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis. AJR Am J Roentgenol 2012; 199: 822-829.
94. Thormer G, Otto J, Reiss-Zimmermann M, et al. Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol 2012; 22: 1820-1828.
95. Rosenkrantz AB, Mannelli L, Kong X, et al. Prostate cancer: utility of fusion of T2-weighted and high b-value diffusion-weighted images for peripheral zone tumor detection and localization. J Magn Reson Imaging 2011; 34: 95-100.
96. Hoeks CMA, Barentsz JO, Hambrock T, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011; 261: 46-66.
97. Pang Y, Turkbey B, Bernardo M, et al. Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations. Magn Reson Med 2013; 69: 553-562.
98. Mazaheri Y, Vargas HA, Akin O, Goldman DA, Hricak H,. Reducing the influence of b-value selection on diffusion-weighted imaging of the prostate: evaluation of a revised monoexponential model within a clinical setting. J Magn Reson Imaging 2012; 35: 660-668.
99. Rosenkrantz AB, Sigmund EE, Johnson G, et al. Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. Radiology 2012; 264: 126-135.
100. Oto A, Yang C, Kayhan A, et al. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. AJR Am J Roentgenol 2011; 197: 1382-1390.
101. Nagarajan R, Margolis D, Raman S, et al. Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer. Adv Urol 2012;2 012: 374805.
102. Litjens GJS, Hambrock T, Hulsbergen-van de Kaa C, Barentsz JO, Huisman HJ,. Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness. Radiology 2012; 265: 260-266.
103. Busard MPH, Mijatovic V, van Kuijk C, Pieters-van den Bos IC, Hompes PGA, van Waesberghe JHTM,. Magnetic resonance imaging in the evaluation of (deep infiltrating) endometriosis: the value of diffusion-weighted imaging. J Magn Reson Imaging 2010; 32: 1003-1009.
104. Inada Y, Matsuki M, Nakai G, et al. Body diffusion-weighted MR imaging of uterine endometrial cancer: is it helpful in the detection of cancer in nonenhanced MR imaging? Eur J Radiol 2009; 70: 122-127.
105. Chen J, Zhang Y, Liang B, Yang Z,. The utility of diffusion-weighted MR imaging in cervical cancer. Eur J Radiol 2010; 74: e101-e106.
106. Hoogendam JP, Klerkx WM, de Kort GAP, et al. The influence of the b-value combination on apparent diffusion coefficient based differentiation between malignant and benign tissue in cervical cancer. J Magn Reson Imaging 2010; 32: 376-382.
107. Thomassin-Naggara I, Toussaint I, Perrot N, et al. Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology 2011; 258: 793-803.
108. Thoeny HC, Forstner R, De Keyzer F,. Genitourinary applications of diffusion-weighted MR imaging in the pelvis. Radiology 2012; 263: 326-342.
109. Sala E, Priest AN, Kataoka M, et al. Apparent diffusion coefficient and vascular signal fraction measurements with magnetic resonance imaging: feasibility in metastatic ovarian cancer at 3 Tesla: technical development. Eur Radiol 2010; 20: 491-496.
110. Sala E, Kataoka MY, Priest AN, et al. Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects. Radiology 2012; 263: 149-159.
111. Tang L, Zhang X-P, Sun Y-S, et al. Gastrointestinal stromal tumors treated with imatinib mesylate: apparent diffusion coefficient in the evaluation of therapy response in patients. Radiology 2011; 258: 729-738.
112. Avcu S, Arslan H, Unal O, Kotan C, Izmirli M,. The role of diffusion-weighted MR imaging and ADC values in the diagnosis of gastric tumors. JBR-BTR 2012; 95: 1-5.
113. Sakurada A, Takahara T, Kwee TC, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in esophageal cancer. Eur Radiol 2009; 19: 1461-1469.
114. Aoyagi T, Shuto K, Okazumi S, et al. Apparent diffusion coefficient correlation with oesophageal tumour stroma and angiogenesis. Eur Radiol 2012; 22: 1172-1177.
115. Oussalah A, Laurent V, Bruot O, et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010; 59: 1056-1065.
116. Kiryu S, Dodanuki K, Takao H, et al. Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn's disease. J Magn Reson Imaging 2009; 29: 880-886.
117. Kilickesmez O, Atilla S, Bayramoglu S, Gurmen N,. Diffusion-weighted imaging of the rectosigmoid colon. J Comput Assist Tomogr 2009; 33: 863-866.
118. Kbox drawings light down and leftlbox drawings light down and leftckesmez O, Soylu A, Yaşar N, et al. Is quantitative diffusion-weighted MRI a reliable method in the assessment of the inflammatory activity in ulcerative colitis? Diag interv Radiol 2010; 16: 293-298.
119. Ichikawa T, Erturk SM, Motosugi U, et al. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006; 187: 181-184. (Pubitemid 46100166)
120. Hosonuma T, Tozaki M, Ichiba N, et al. Clinical usefulness of diffusion-weighted imaging using low and high b-values to detect rectal cancer. Magn Reson Med 2006; 5: 173-177.
121. Yoshikawa T, Kawamitsu H, Mitchell DG, et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 2006; 187: 1521-1530. (Pubitemid 44788683)
122. Schoennagel BP, Habermann CR, Roesch M, et al. Diffusion-weighted imaging of the healthy pancreas: apparent diffusion coefficient values of the normal head, body, and tail calculated from different sets of b-values. J Magn Reson Imaging 2011; 34: 861-865.
123. Wiggermann P, Grützmann R, Weissenbock A, Kamusella P, Dittert D-D, Stroszczynski C,. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis. Acta Radiol 2012; 53: 135-139.
124. Kamisawa T, Takuma K, Anjiki H, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol 2010; 105: 1870-1875.
125. Ichikawa T, Erturk SM, Motosugi U, et al. High-b value diffusion-weighted MRI for detecting pancreatic adenocarcinoma: preliminary results. AJR Am J Roentgenol 2007; 188: 409-414. (Pubitemid 46167742)
126. Fukukura Y, Takumi K, Kamimura K, et al. Pancreatic adenocarcinoma: variability of diffusion-weighted MR imaging findings. Radiology 2012; 263: 732-740.
127. Mottola JC, Sahni VA, Erturk SM, Swanson R, Banks PA, Mortele KJ,. Diffusion-weighted MRI of focal cystic pancreatic lesions at 3.0-Tesla: preliminary results. Abdom Imaging 2012; 37: 110-117.
128. Klauss M, Lemke A, Grunberg K, et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Invest Radiol 2011; 46: 57-63.
129. Lemke A, Laun FB, Klauss M, et al. Differentiation of pancreas carcinoma from healthy pancreatic tissue using multiple b-values: comparison of apparent diffusion coefficient and intravoxel incoherent motion derived parameters. Invest Radiol 2009; 44: 769-775.
130. Kartalis N, Lindholm TL, Aspelin P, Permert J, Albiin N,. Diffusion-weighted magnetic resonance imaging of pancreas tumours. Eur Radiol 2009; 19: 1981-1990.
131. Brenner R, Metens T, Bali M, Demetter P, Matos C,. Pancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection. Eur J Radiol 2012; 81: e746-e749.
132. Holzapfel K, Bruegel M, Eiber M, et al. Characterization of small (≤10 mm) focal liver lesions: value of respiratory-triggered echo-planar diffusion-weighted MR imaging. Eur J Radiol 2010; 76: 89-95.
133. Kim DJ, Yu J-S, Kim JH, Chung J-J, Kim KW,. Small hypervascular hepatocellular carcinomas: value of diffusion-weighted imaging compared with "washout" appearance on dynamic MRI. Br J Radiol 2012; 85: e879-e886.
134. Le Moigne F, Durieux M, Bancel B, et al. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. Magn Reson Imaging 2012; 30: 656-665.
135. Park M-S, Kim S, Patel J, et al. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients. Hepatology 2012; 56: 140-148.
136. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18: 477-485. (Pubitemid 351248179)
137. Bonekamp S, Corona-Villalobos CP, Kamel IR,. Oncologic applications of diffusion-weighted MRI in the body. J Magn Reson Imaging 2012; 35: 257-279.
138. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 2008; 246: 812-822.
139. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H,. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210: 617-623. (Pubitemid 29124018)
140. Donati F, Boraschi P, Gigoni R, Salemi S, Falaschi F, Bartolozzi C,. Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics. Magn Reson Imaging 2013; 1: 10-16.
141. Agnello F, Ronot M, Valla DC, Sinkus R, Van Beers BE, Vilgrain V,. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. Radiology 2012; 262: 511-519.
142. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008; 249: 891-899.
143. Patel J, Sigmund EE, Rusinek H, Oei M, Babb JS, Taouli B,. Diagnosis of cirrhosis with intravoxel incoherent motion diffusion MRI and dynamic contrast-enhanced MRI alone and in combination: preliminary experience. J Magn Reson Imaging 2010; 31: 589-600.
144. Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, Minami M,. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. AJR Am J Roentgenol 2009; 193: 438-444.
145. Li SP, Padhani AR,. Tumor response assessments with diffusion and perfusion MRI. J Magn Reson Imaging 2012; 35: 745-763.